Nabla is an AI-native biotech company combining cutting edge generative models with massively multiplex functional screens to design therapeutic antibodies against the most difficult targets. Nabla's founders built the first protein language models as grad students in George Church's Harvard lab and have continued to advance the frontier of technology and translation.